Similar Search Results

Manning, Richard L. - In: International journal of the economics of business 25 (2018) 1, pp. 157-166

Persistent link: https://www.econbiz.de/10011881466

Financialized corporations in a national innovation system : the US pharmaceutical industry

Tulum, Öner; Lazonick, William - In: International journal of political economy : a journal … 47 (2018) 3/4, pp. 281-316

Persistent link: https://www.econbiz.de/10012206207

U.S. pharmaceutical markets : expenditures, health insurance, new products and generic prescribing from 1960 to 2016

Lu, Z. John; Comanor, William S.; Cherkas, Elliot; … - In: International journal of the economics of business 27 (2020) 1, pp. 1-26

Persistent link: https://www.econbiz.de/10012182277

Generics and New Goods in Pharmaceutical Price Indexes

Griliches, Zvi - 1993

We examine the issue of new goods and price indexes for the important and tractable case of generic and branded drugs. By treating generics as entirely distinct goods and "linking them in" to indexes with fixed weights, the standard price indexes fail to reflect the substantial welfare gains to...

Persistent link: https://www.econbiz.de/10012474690

Free-riding in pharmaceutical price regulation : theory and evidence

Pertile, Paolo; Gamba, Simona; Forster, Martin - 2018

Persistent link: https://www.econbiz.de/10011869307

Pharmaceutical Innovation and Access to Medicines

OECD - 2018

This report reviews the important role of medicines in health systems, describes recent trends in pharmaceutical expenditure and financing, and summarises the approaches used by OECD countries to determine coverage and pricing. It then highlights current issues for policy makers, such as the...

Persistent link: https://www.econbiz.de/10012450998

Unpacking the effects of adverse regulatory events : Evidence from pharmaceutical relabeling

Higgins, Matthew J.; Yan, Xin; Chatterjee, Chirantan - In: Research policy : policy, management and economic … 50 (2021) 1, pp. 1-15

Persistent link: https://www.econbiz.de/10012663313

Mapping the strength of sectoral innovation system in the Nigerian pharmaceutical industry : empirical evidence

Ayo-Lawal, Rachael Aderonke; Adelowo, Caleb Muyiwa; … - In: African journal of science, technology, innovation and … 15 (2023) 2, pp. 198-210

Persistent link: https://www.econbiz.de/10014251267

The Globalization of Innovation : Pharmaceuticals: Can India and China Cure the Global Pharmaceutical Market

Wadhwa, Vivek; Rissing, Ben A.; Gereffi, G.; Trumpbour, John - 2014

Multinational pharmaceutical corporations are searching for means to broaden their capacity for drug development while decreasing costs. Pharmaceutical firms in India and China are increasingly forging partnerships with these corporations to gain revenue and to develop their own expertise. These...

Persistent link: https://www.econbiz.de/10014047447

Pharmaceutical Arbitrage : Balancing Access and Innovation in International Prescription Drug Markets

Outterson, Kevin - 2014

pharmaceuticals, the empirical results are more complex. Pharmaceutical regulation, IP laws, global trade agreements, and company … appropriate for consumer welfare. The usual defense of the practice within the OECD is grounded in the need for innovation … can be provided to low and middle income populations for all global diseases without harming innovation. By contrast …

Persistent link: https://www.econbiz.de/10014070573